The science behind Cereboost™

Clinically proven benefits for memory, attention, energy and mood

Supported by patents, Cereboost™ derives its power from a formula of six ginsenosides – adaptogens that occur naturally in American Ginseng. Just 200 mg of Cereboost™ a day delivers sufficient quantities of ginsenosides to provide a positive effect, with benefits for memory, attention, energy and mood that have been documented in human clinical trials published in peer-reviewed journals. ⁴ ⁵ ⁶ ⁷

6
Cereboost specific health claims awarded worldwide⁹⁻¹⁰

Multiple clinical studies

Multiple clinical studies – conducted with diverse populations over a 10-year period – have shown that Cereboost™ delivers benefits for memory, attention, energy and mood.⁴ ⁵ ⁶ ⁷ These clinical studies conducted in collaboration with recognised global experts, have been published in peer-reviewed journals.

This includes the following human clinical studies:

  • 2010 (Scholey et al): Young adults who consumed Cereboost™ registered significant improvements to working memory, attention and mood⁴
  • 2015 (Ossoukhova A. et al).: Improved working memory performance in healthy middle-age adults⁷
  • 2020 (White et al): Demonstrated that Cereboost™ helps activate the prefrontal cortex during cognitive tasks⁵
  • 2022 (Bell et al): Found that chronic consumption of Cereboost™ significantly improved attention, reduced fatigue, and increased feelings of self-assurance among young adults⁶

Effect on the gut-brain axis

Cereboost™ could owe its scientifically proven benefits in part to its effect on the gut-brain axis. Recent in-vitro data suggest that the mechanism of action of Cereboost™ may be associated with increased levels of certain gut microbes (Lactobacillus and Akkermansia species) and short-chain fatty acids associated with cognitive health. This may be linked with memory and mood benefits, while boosting the key neurotransmitter levels and helping to activate the prefrontal cortex.⁶ ⁸

Learn More

Understanding the science of Cereboost

Health claims in three different countries

The science supporting Cereboost™ has led regulators in Canada and Japan to approve health claims for cognitive function, memory, energy and mood.

Canada (Health Canada)⁹

The use of the following claims is allowed for a daily dose of 200 mg:

  • Helps support attention in healthy individuals
  • Helps reduce mental fatigue
  • Helps support cognitive function/performance
  • Helps support working memory

Japan (FFC)¹⁰

The use of the following claims is allowed for a daily dose of 200 mg:

  • To help alleviate temporary fatigue
  • To temporarily improve mood and alleviate anxiety

France (DGCCRF)¹¹

Pending Health Claim:

  • Improves concentration and coordination
References
Disclaimer
This web page is intended to provide business-to-business education and information. Its purpose is not intended to communicate to end consumers. Ingredient information is for educational purposes only; specific ingredients are not intended to prevent, treat, mitigate or cure any disease states. This information is not intended to be used in final consumer products and any use or reference of the intellectual property of Givaudan in the final product may only be made with Givaudan’s prior written permission. The information provided may or may not be applicable to, or satisfy, all regulatory requirements for all global regions. Specific regulatory requirements must be evaluated to ensure compliance within the individual countries and regions.
*